BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2985854)

  • 1. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant metastatic insulinoma treated with streptozotocin.
    Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin. Review of 21 cases described in detail in the literature and report of complete remission of a new case.
    Herbai G; Lundin A
    Acta Med Scand; 1976; 200(6):447-52. PubMed ID: 189576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A malignant insulinoma transformed into a glucagonoma syndrome.
    Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
    Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
    [No Abstract]   [Full Text] [Related]  

  • 5. [Streptozotocin treatment of an insulinoma with hepatic metastases].
    Guilmot JL; Choutet P; Perrotin D; Ginies G; Lamisse F
    Nouv Presse Med; 1979 Oct; 8(38):3055-6. PubMed ID: 230458
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases.
    Blum I; Rusecki Y; Doron M; Lahav M; Laron Z; Atsmon A
    J Endocrinol Invest; 1983 Feb; 6(1):41-5. PubMed ID: 6302161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
    Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
    Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
    Granuci P; Mahler RJ
    Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune reactions in a patient with malignant insulinoma treated by multiple low dose streptozotocin.
    Schulz B; Hehmke B; Zander E; Ziegler B
    Exp Clin Endocrinol; 1990 Feb; 95(1):77-82. PubMed ID: 2159401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.
    Del Prato S; Rovira A; Tessari P; Avogaro A; Nosadini R; Valverde I; Trevisan R; Tiengo A
    J Endocrinol Invest; 1984 Apr; 7(2):111-5. PubMed ID: 6327796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced diuresis to reduce nephrotoxicity of streptozotocin in the treatment of advanced metastatic insulinoma.
    Tobin MV; Warenius HM; Morris AI
    Br Med J (Clin Res Ed); 1987 May; 294(6580):1128. PubMed ID: 3034373
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin and C-peptide in plasma and tumor of insulinoma patients.
    Ohneda A; Sakai T; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant insuloma. Evaluation of the response to treatment with streptozotocin, using selective arteriography of the celiac axis].
    Neri G; Caresano A; Croce F
    Minerva Med; 1978 Jun; 69(29):1983-90. PubMed ID: 210429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
    Nesović M; Cirić J; Radojković S; Zarković M; Durović M
    J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.
    Murray-Lyon IM; Eddleston AL; Williams R; Brown M; Hogbin BM; Bennett A; Edwards JC; Taylor KW
    Lancet; 1968 Oct; 2(7574):895-8. PubMed ID: 4176152
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of streptozotocin on an islet cell carcinoma with hypercalcemia.
    DeWys WD; Stoll R; Au WY; Salisnjak MM
    Am J Med; 1973 Nov; 55(5):671-6. PubMed ID: 4356099
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.